Product Categories
Country: | China |
---|---|
Tel: | 010-010-52878169 |
Mobile: | 15801002657 |
E-mail: | |
QQ: | |
Skype: | Chat Now! |
Product Name | MF | CAS | Details |
---|
2-Pyrrolidinone | C4H7NO | 616-45-5 | Details |
tert-butyl ((1S,2R,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2- oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamate | C21H30ClN5O5 | 2024614-15-9 | Details |
tert-butyl ((1R,2R,5S)-2-(2-((5-chloropyridin-2-yl)amino)-2- oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamate | C21H30ClN5O5 | 480451-98-7 | Details |
(2R,5R)-5-Hydroxy-1,3-oxathiolane-2-carboxylic acid (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester | C14H24O4S | 147126-62-3 | Details |
Edoxaban Impurity 26 (1R,2S,4R) | C21H30ClN5O5 | 1255529-33-9 | Details |
tert-butyl ((1R,2R,5R)-2-(2-((5-chloropyridin-2-yl)amino)-2-oxoacetamido)-5-(dimethylcarbamoyl)cyclohexyl)carbamate | C21H30ClN5O5 | 1255529-38-4 | Details |
sodium (6R,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl- 1,3,4-thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate | Details |
6,6'-oxybis(3-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile) | Details |
1-(4-(4-methylpiperazin-1-yl)-2-thioxo-1,2-dihydro-3H-benzo[b][1,4] diazepin-3-ylidene)propan-2-one | C17H20N4OS | 1902955-67-2 | Details |
N-(5-((diphenylphosphoryl)methyl)-4-(2-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide | Details |
Benzene,1-ethoxy-4-(phenylmethyl)- | C15H16O | 35672-52-7 | Details |
N-(5-((diphenylphosphoryl)methyl)-4-(3-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide | Details |
(R)-2-(butylsulfonamido)-3-(4-(4-(piperidin-4-yl)butoxy)phenyl) propanoic acid | C22H36N2O5S | 158808-86-7 | Details |
2-(1-((2-(1-hydroxypentyl)benzoyl)oxy)pentyl)benzoic acid | C24H30O5 | 1841089-56-2 | Details |
(R)-2-(2-aminothiazol-4-yl)-N-(4-(2-((4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)amino)-2-oxoethyl)thiazol-2-yl)acetamide 2,2,2-trifluoroacetate | Details |
N-Butylsulfonyl-O-(4-(4-pyridinyl)butyl)-L-tyrosine | C22H30N2O5S | 149490-61-9 | Details |
Acetamide,N-(2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl)- | C10H8N2O3 | 6118-65-6 | Details |
Folitixorin (Mixture of DiastereoMers) | C20H23N7O6 | 3432-99-3 | Details |
sodium (R,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate | C12H18NNaO6S | 130609-10-8 | Details |
Apremilast Impurity 28 | C30H27N3O9S | 1802246-60-1 | Details |
(Z)-ethyl 3-ethoxy-2-(2,4,5-trifluoro-3-methoxybenzoyl)acrylate | C15H15F3O5 | 866954-86-1 | Details |
(Z)-ETHYL 3-(CYCLOPROPYLAMINO)-2-(2,4,5-TRIFLUORO-3-METHOXYBENZOYL)ACRYLATE | C16H16F3NO4 | 112811-70-8 | Details |
N-(2-(1-(3-hydroxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3- dioxoisoindolin-4-yl)acetamide | Details |
Apremilast Impurity 19 | C22H24N2O7S | 2201974-01-6 | Details |
Clindamycin phosphate | C18H34ClN2O8PS | 24729-96-2 | Details |
(2S,4S)-Argatroban | C23H36N6O5S | 189264-03-7 | Details |
4-[N-(2,4-DIAMINO-6-PTERIDINYLMETHYL)-N-METHYLAMINO] BENZOIC ACID | C15H15N7O2 | 19741-14-1 | Details |
2'',3'',5''-Triacetyl -azacytidine | C14H18N4O8 | 10302-78-0 | Details |
N-((2-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)butyramide | C16H14N2O3S | 2304623-36-5 | Details |
Benzenesulfonamide, 2-(5-methyl-3-phenyl-4-isoxazolyl)- | C16H14N2O3S | 2304623-35-4 | Details |
cefoperazone A | C25H29N9O9S2 | 73240-07-0 | Details |
2-(2-Aminothiazole-4-yl)-2-methoxyiminoacetic acid | C6H7N3O3S | 65872-41-5 | Details |
Clindamycin Phosphate impurity 13-1 | C18H34ClN2O9PS | 887402-20-2 | Details |
(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4-oxide | Details |
Ceftriaxone sodium impurity 13 | C14H8N2S4 | 120-78-5 | Details |
(S)-2-(butylsulfonamido)-3-(3-chloro-4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic acid hydrochloride | C22H35ClN2O5S | 2713130-63-1 | Details |
N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3- dioxoisoindolin-4-yl)acetamide | C21H22N2O7S | 1384441-38-6 | Details |
(R)-2-(4-((((S)-2-amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid | Details |
(2S,4S)-4-methyl-1-(((3-methyl-1,2,3,4-tetrahydroquinolin-8-yl) sulfonyl)-D-arginyl)piperidine-2-carboxylic acid | Details |
Argatroban Impurity J | Details |
(2R,4S)-4-methyl-1-(((3-methyl-1,2,3,4-tetrahydroquinolin-8-yl) sulfonyl)-L-arginyl)piperidine-2-carboxylic acid | C23H36N6O5S | 189264-04-8 | Details |
(2R,3R,4S,5R,6R)-6-((1S,2S)-2-chloro-1-((2S,4R)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-((R)-methylsulfinyl)tetrahydro-2H-pyran-3-yl dihydrogen phosphate | Details |
6-carbamimidoylnaphthalen-2-yl 4-ureidobenzoate methanesulfonate | Details |
4-guanidino-N-((6-hydroxynaphthalen-2-yl)(imino)methyl)benzamide hydrochloride | Details |
(S)-3-((2R,5S)-2-((S)-(4-(benzyloxy)phenyl)((4-fluorophenyl)amino)methyl)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one | C40H36F2N2O5 | 1185883-39-9 | Details |
3-acetamidophthalic acid | C10H9NO5 | 15371-06-9 | Details |
Benzoic acid, 3-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl ester | C19H17N5O2 | 82956-09-0 | Details |
Apremilast Impurity FA | C21H22N2O7S | 2077897-94-8 | Details |
Pyridine, 3-(4,5-dihydro-2-oxazolyl)- | C8H8N2O | 40055-37-6 | Details |
Apremilast Impurity 4 | C12H16O4S | 1831833-38-5 | Details |
Apremilast Impurity HS093313 | C20H21NO6S | 2077897-93-7 | Details |
Tedizolid Impurity 27 | C10H9BrFNO3 | 2044710-49-6 | Details |
Ezetimibe Impurity 33 | Details |
Ezetimibe Impurity 36 | Details |
4-((2R,6S)-6-(4-fluorophenyl)tetrahydro-2H-pyran-2-yl)phenol | C20H21NO4 | 2280081-69-6 | Details |
(R)-2-(4-(((2-amino-4-oxo-4,8-dihydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid | C19H19N7O6 | 65165-91-5 | Details |
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate | Details |
1-(1-((1,4-dihydropyridin-3-yl)sulfonyl)-5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine | C17H18FN3O2S | 2416241-98-8 | Details |
Cefoperazone impurity02 | C25H27N9O9S2 | 67275-31-4 | Details |
Cefoperazone impurity03 | C25H27N9O9S2 | 67275-30-3 | Details |
2-acetamido-N-benzyl-2-(benzylamino)propanamide | Details |
(R)-(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate | C24H36O5 | 79952-44-6 | Details |
(1R,1'R,2R,2'R)-2,2'-((hexane-1,6-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium) | C60H79N2O15S+ | 1193104-85-6 | Details |
SiMvastatin 4'-Methyl Ether | C26H40O5 | 864357-88-0 | Details |
Simvastatin ammonium salt | C25H43NO6 | 139893-43-9 | Details |
Glycine,N-(N-L-γ-glutamyl-D-cysteinyl)- | C10H17N3O6S | 128960-77-0 | Details |
(3R,5R)-ethyl 7-((1S,2S,6R,8S,8aR)-8-((2,2-dimethylbutanoyl)oxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoate | C27H44O6 | 864357-87-9 | Details |
Glycine, N-(N-D-γ-glutamyl-L-cysteinyl)- | C10H17N3O6S | 108457-42-7 | Details |
glutathione | C10H17N3O6S | 274260-05-8 | Details |
(3R,5R)-7-((1S,2S,6R,8S,8aR)-8-((2,2-dimethylbutanoyl)oxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic acid | C25H41NaO6 | 101314-97-0 | Details |
2’’-Desethyl-2’’-vinyl Simvastatin | C25H36O5 | 1449248-72-9 | Details |
Dehydro Simvastatin | C25H36O4 | 210980-68-0 | Details |
Simvastatin Impurity 39 | C23H34O5 | 79902-42-4 | Details |
(2S)-2-amino-5-(((2R)-1-((carboxymethyl)amino)-1-oxo-3-sulfinopropan-2-yl)amino)-5-oxopentanoic acid | C10H17N3O8S | 17297-99-3 | Details |
2-amino-9-(((2-chloroallyl)oxy)methyl)-1H-purin-6(9H)-one | C9H10ClN5O2 | 1797982-93-4 | Details |
MONACOLIN J | C19H28O4 | 79952-42-4 | Details |
6-carbamoylnaphthalen-2-yl 4-ureidobenzoate | Details |
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium | C28H35NO7S | 2480467-84-1 | Details |
2,6-Dibenzyloxyacetophenone | C22H20O3 | 3886-19-9 | Details |
Fluconazole Impurity 5 | C10H9ClF2N4O | 154534-83-5 | Details |
Lenvatinib Impurity g | C21H20N4O4 | 417714-14-8 | Details |
Voriconazole Impurity 16 | C10H7F2N3O | 1157981-64-0 | Details |
(1R,2R)-2-(3-((5-acetoxypentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium | Details |
Simvastatin impurity04 | C50H76O10 | 476305-24-5 | Details |
(S)-N-(1-Azabicyclo[2.2.2]oct-3-yl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamide | C18H24N2O | 135729-78-1 | Details |
2-acetamido-N-benzylacrylamide | C12H14N2O2 | 86921-49-5 | Details |
ACETYLSIMVASTATIN | C27H40O6 | 145576-25-6 | Details |
XXZJUZXKBFUPQH-IKGGRYGDSA-N | C18H17FO4 | 1618657-31-0 | Details |
(R)-2-amino-N-benzyl-3-methoxypropanamide | C11H16N2O2 | 196601-69-1 | Details |
(E)-3-(4-((3-(1-(4-((1H-imidazol-1-yl)methyl)phenyl)-2-carboxyethyl)-1H-imidazol-3-ium-1-yl)methyl)phenyl)acrylate | Details |
P-TOLYL-PROPYNOIC ACID ETHYL ESTER | C12H12O2 | 52188-06-4 | Details |
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline | C21H27NO4 | 85-63-2 | Details |
Cistracurium Besylate EP Impurity D | C31H39NO9S | 1075726-88-3 | Details |
(1R,2R)-2-(3-((5-(acryloyloxy)pentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxy benzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium 2,2,2- trifluoroacetate | C38H49NO11S | 155913-31-8 | Details |
(4-((((S)-2-amino-8-methyl-4,9-dioxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a][1,3,5]triazin-7-yl)methyl)amino)benzoyl)-L-glutamic acid | C20H23N7O7 | 79573-48-1 | Details |
1-(3,5-bis(benzyloxy)phenyl)-2-(tert-butylamino)ethan-1-ol hydrochloride | C26H31NO3 | 28924-25-6 | Details |
(S)-2-(4-((((S)-5-methyl-2-(methylamino)-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 |